Regenerative Medical Technology Group Inc. (RMTG)

Every figure this model derived for RMTG, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 850,894 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 1,323,304 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 2,284,678 AssetsCurrent 2026-06-30
current liabilities 42,613,096 LiabilitiesCurrent 2026-06-30
equity -39,255,516 StockholdersEquity 2026-06-30
interest expense 9,922,905 InterestExpenseNonoperating 2026-06-30
ocf 268,563 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 9,414,572 Revenues 2026-06-30
sbc 0 ShareBasedCompensation 2019-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up RMTG on one particular measure came for.

RatioValue
cash operating margin4.32
current ratio0.05
current ratio reported0.05
deferred revenue growth254.71
dilution pct0.82
ebit yoy-84.67
fcf margin-6.19
growth cv1.14
interest cover0.0
net debt ebitda2.03
operating margin0.46
owner earnings margin-6.19
revenue growth94.32
revenue growth per share92.74
rule of 4094.79
sbc pct revenue0.0

What to be careful about

What this model itself distrusts about RMTG's figures. Written by the derivation as it ran, not added afterwards.